share_log

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%), etc.

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%), etc.

Aslan Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%)等
美股sec公告 ·  03/19 22:29
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息